Suppr超能文献

长期使用他莫昔芬与卵巢癌肉瘤相关:病例报告。

Ovarian carcinosarcomas associated with prolonged use of tamoxifen: case reports.

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel.

出版信息

Int J Gynecol Cancer. 2009 Dec;19(9):1521-3. doi: 10.1111/IGC.0b013e3181a83fbf.

Abstract

BACKGROUND

Recent studies have indicated that the risk associated with tamoxifen may be substantially higher for uterine malignant mixed müllerian tumors and uterine sarcomas.

CASE

We present 2 cases of ovarian carcinosarcomas in patients with a personal history of breast carcinoma who were treated for a prolonged period with tamoxifen.

CONCLUSIONS

To our knowledge, these 2 cases are the first to describe the possible association between ovarian carcinosarcomas and previous personal and familial history of breast carcinoma and\or prolonged use of tamoxifen. These cases may suggest that like in the uterus, tamoxifen has a possible delayed effect, which might be responsible for the formation of aggressive tumors of unclear pathogenesis in the ovaries.

摘要

背景

最近的研究表明,他莫昔芬与子宫恶性混合米勒管肿瘤和子宫肉瘤相关的风险可能显著增加。

病例

我们报告了 2 例卵巢癌肉瘤病例,这些患者均有乳腺癌个人病史,并长期接受他莫昔芬治疗。

结论

据我们所知,这 2 例病例首次描述了卵巢癌肉瘤与乳腺癌个人和家族病史以及/或长期使用他莫昔芬之间可能存在的关联。这些病例可能表明,与子宫一样,他莫昔芬可能具有延迟作用,这可能导致卵巢中形成发病机制不明的侵袭性肿瘤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验